Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Update

2 Sep 2015 07:00

RNS Number : 7726X
Diploma PLC
02 September 2015
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

2 September 2015

 

 

DIPLOMA PLC

 

TRADING UPDATE

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a Trading Update for the year ending 30 September 2015.

 

Trading Summary

Reported revenues for the year ending 30 September 2015 are expected to increase by ca. 9% with acquisitions incrementally contributing ca. 10% to Group revenue, offset by a reduction of ca. 2% in revenues from translational currency effects. The headwinds to organic growth identified at the Half Year have continued and in certain cases strengthened through the second half of the year and on an underlying basis, after adjusting for currency effects and acquisitions, Group revenues are expected to increase by ca. 1%.

 

In Life Sciences, revenue growth has strengthened as anticipated in the second half of the year, helped by stronger capital equipment sales; underlying revenue growth for the full year is expected to be ca. 3%. In Seals, trading activity in the North American Aftermarket business slowed in the second half of the year as demand was impacted indirectly by cut-backs in the Oil & Gas sector; there was also a significant reduction in demand for HKX's excavator attachment kits against a very strong prior year comparative. The Industrial OEM Seal businesses, both in Europe and the US also softened after a strong first half and full year underlying revenue growth for Seals is expected to be ca. 4%. In Controls, market conditions remain broadly unchanged from those experienced in the first half of the year with weak activity in most European industrial markets; underlying revenues are expected to be ca. 5% below FY2014.

 

Underlying operating margins have generally remained robust and broadly consistent with the first half of the year; however a facility closure and relocation in the US Seals business, together with the impact of the initial lower margins in the acquired businesses is expected to lead to a reduction of ca. 50bps in Group operating margin for the full year compared with the first half figure. The further weakening, in the second half of the year, of the C$ and A$ against the US$ has largely been mitigated by existing currency hedging contracts; however this weakening will impact next year's operating margins in the Group's Healthcare businesses as existing currency hedging contracts expire and are replaced by more expensive contracts.

 

Acquisitions

Acquisitions are a key part of the Group's growth strategy. In the year to date, the Group has spent ca. £38m on acquisitions, including the acquisition in July 2015 of a small Seals Aftermarket business in the UK. The pipeline for further acquisitions during the next six months remains promising.  

 

Financial Position

Free cash flow remains strong, although with increased capital expenditure, the Group's free cash flow for the year ending 30 September 2015 is likely to remain broadly similar to last year. The Group's balance sheet is robust with net cash funds at 30 September 2015 expected to be a small positive and supported by a £40m multi-currency revolving facility with an accordion option to increase this to £50m.

 

The Group's results for the year ended 30 September 2015 will be announced on Monday, 16 November 2015.

 

Conference Call:

 

A conference call for analysts and investors will take place at 8.15am (GMT) this morning. This conference call can be accessed by dialling +44 (0) 20 3139 4830 and pin code 56063221#. A replay of this call will be available by dialling +44 (0) 20 3426 2807 and pin code 661455# for a period of 30 days after the event.

 

 

Notes:

 

1. This Trading Update, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC .It should not be relied on by any other party, for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

 

Our businesses then design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment.

 

The Group employs ca. 1,400 employees and its principal operating businesses are located in the UK, Northern Europe, North America and Australia.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 20% p.a. through a combination of organic growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. £800m.

 

Further information on Diploma PLC can be found at www.diplomaplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQFLFBEKFEBBF
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.